![Deya Corzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Deya Corzo worked as an Executive Director-Medical at Celgene Corp.
from 2012 to 2014.
She then worked as SVP-Research & Development, Head-Therapeutic Area at uniQure NV from 2014 to 2017.
From 2017 to 2018, she served as Chief Medical Officer at Sojournix, Inc. and from 2018 to 2021, she worked as Chief Medical Officer at Sigilon Therapeutics, Inc. Dr. Corzo holds a doctorate degree from Universidad Industrial de Santander.
Eerdere bekende functies van Deya Corzo
| Bedrijven | Functie | Einde |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2021 |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| UNIQURE N.V. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 |
| CELGENE | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Deya Corzo
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Universidad Industrial de Santander
 Universidad Industrial de Santander Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
